S Thomas Selected Research

Nafronyl (Naftidrofuryl)

12/2012	Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.
12/2011	A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Thomas Research Topics

Disease

17	Wounds and Injuries (Trauma) 12/2016 - 01/2000
13	Neoplasms (Cancer) 01/2021 - 01/2000
8	Infections 06/2020 - 09/2001
7	Breast Neoplasms (Breast Cancer) 01/2013 - 04/2006
6	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2018 - 03/2000
6	Hemolysis 06/2016 - 10/2011
6	Necrosis 08/2015 - 02/2007
5	Wound Infection (Wound Infections) 02/2009 - 10/2001
4	Pneumonia (Pneumonitis) 01/2017 - 10/2001
4	Myocardial Infarction 10/2015 - 10/2006
4	Inflammation (Inflammations) 10/2015 - 09/2000
3	Sepsis (Septicemia) 01/2022 - 01/2001
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 10/2014
3	Body Weight (Weight, Body) 01/2020 - 10/2000
3	Fatigue 01/2016 - 01/2006
3	Insulin Resistance 08/2014 - 03/2000
3	Intermittent Claudication 12/2013 - 12/2011
3	Synovitis 07/2013 - 01/2011
3	Pain (Aches) 11/2009 - 01/2006
3	Abscess 01/2008 - 05/2001
3	Ulcer 08/2007 - 09/2001
3	Weight Gain 04/2007 - 09/2000
3	Type 2 Diabetes Mellitus (MODY) 04/2007 - 03/2004
3	Leg Ulcer 12/2001 - 02/2000
2	Skin Neoplasms (Skin Cancer) 02/2022 - 03/2014
2	COVID-19 01/2021 - 01/2021
2	Periodontitis 01/2021 - 01/2020
2	Down Syndrome (Down's Syndrome) 11/2020 - 01/2003
2	Cognitive Dysfunction 11/2020 - 09/2016
2	Fibrosis (Cirrhosis) 01/2020 - 10/2011
2	Psychotic Disorders (Schizoaffective Disorder) 10/2019 - 07/2012
2	Hypothyroidism 10/2018 - 07/2009
2	Critical Illness (Critically Ill) 07/2018 - 01/2017
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2017 - 08/2001
2	Vomiting 10/2017 - 02/2007
2	Head and Neck Neoplasms (Head and Neck Cancer) 04/2016 - 02/2009
2	Thrombocytopenia (Thrombopenia) 01/2016 - 09/2013
2	Hemorrhage 06/2015 - 09/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2014 - 09/2009
2	Leukopenia 09/2013 - 12/2001
2	Anemia 09/2013 - 12/2001
2	Heart Failure 04/2013 - 10/2004
2	Peripheral Arterial Disease 12/2012 - 12/2011
2	Chronic Obstructive Pulmonary Disease (COPD) 04/2012 - 01/2011
2	Osteoarthritis 11/2009 - 04/2002
2	Fever (Fevers) 02/2009 - 09/2000
2	Hypertension (High Blood Pressure) 01/2009 - 05/2004

Drug/Important Bio-Agent (IBA)

8	Pharmaceutical PreparationsIBA 06/2009 - 09/2000
7	Insulin (Novolin)FDA Link 09/2020 - 08/2001
5	Glucose (Dextrose)FDA LinkGeneric 06/2013 - 03/2000
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2000
4	PotassiumIBA 06/2016 - 10/2011
4	Proteins (Proteins, Gene)FDA Link 08/2013 - 09/2001
4	VaccinesIBA 12/2009 - 05/2006
4	Anti-Bacterial Agents (Antibiotics)IBA 08/2007 - 12/2001
4	CreatinineIBA 03/2004 - 03/2000
3	Biological ProductsIBA 04/2020 - 08/2008
3	salicylhydroxamic acid (SHAM)IBA 08/2015 - 01/2002
3	Pentoxifylline (Trental)FDA LinkGeneric 12/2013 - 12/2011
3	OxalatesIBA 12/2013 - 12/2011
3	LipidsIBA 04/2013 - 01/2000
3	InterleukinsIBA 10/2011 - 04/2009
3	Hormones (Hormone)IBA 06/2011 - 10/2000
3	AcidsIBA 01/2008 - 11/2000
3	Thalidomide (Thalomid)FDA Link 11/2000 - 01/2000
3	AlginatesIBA 04/2000 - 02/2000
2	Abiraterone AcetateIBA 01/2021 - 09/2017
2	Adenosine Triphosphate (ATP)IBA 06/2016 - 08/2012
2	Messenger RNA (mRNA)IBA 08/2015 - 08/2013
2	Oxygen (Dioxygen)IBA 08/2015 - 04/2012
2	Indicators and Reagents (Reagents)IBA 04/2014 - 04/2006
2	Rituximab (Mabthera)FDA Link 09/2013 - 04/2008
2	CytokinesIBA 08/2013 - 04/2009
2	YttriumIBA 07/2013 - 01/2011
2	Durapatite (Hydroxylapatite)IBA 07/2013 - 09/2011
2	Cilostazol (Pletal)FDA LinkGeneric 12/2012 - 12/2011
2	Nafronyl (Naftidrofuryl)IBA 12/2012 - 12/2011
2	Citric Acid (Citrate)FDA LinkGeneric 09/2011 - 01/2011
2	Histone Deacetylase InhibitorsIBA 06/2011 - 10/2009
2	Tamoxifen FDA LinkGeneric 06/2011 - 10/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2009 - 02/2007
2	Glycoproteins (Glycoprotein)IBA 01/2009 - 03/2000
2	Peptides (Polypeptides)IBA 01/2009 - 03/2000

Therapy/Procedure

22	Therapeutics 01/2021 - 01/2000
5	Maggot Debridement Therapy 11/2006 - 01/2000
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2013
4	Radiotherapy 10/2014 - 02/2007
4	Transplantation 05/2007 - 09/2001
3	Synovectomy 07/2013 - 01/2011
3	Length of Stay 02/2009 - 10/2001
2	Extracorporeal Membrane Oxygenation 01/2022 - 07/2018
2	Castration 01/2021 - 09/2017
2	Catheters 12/2018 - 07/2007
2	Injections 10/2017 - 01/2017
2	Immunotherapy 01/2017 - 12/2000
2	Stem Cell Transplantation 01/2017 - 09/2000
2	Stents 12/2016 - 10/2009
2	Perioperative Period 06/2015 - 02/2009
2	Sternotomy 11/2011 - 09/2000